title: Accuracy of urine NGAL commercial assays in critically ill patients.
authors.forename: Matthieu
authors.initials: M
authors.lastname: Legrand
authors.forename: Corinne
authors.initials: C
authors.lastname: Collet
authors.forename: Etienne
authors.initials: E
authors.lastname: Gayat
authors.forename: Juliana
authors.initials: J
authors.lastname: Henao
authors.forename: Veronique
authors.initials: V
authors.lastname: Giraudeaux
authors.forename: Joaquim
authors.initials: J
authors.lastname: Mateo
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Launay
authors.forename: Didier
authors.initials: D
authors.lastname: Payen
mesh_terms: D058186:Acute Kidney Injury / Q000175:diagnosis / Q000652:urine; D000209:Acute-Phase Proteins / Q000652:urine*; D000368:Aged; D016638:Critical Illness; D006801:Humans; D000071068:Lipocalin-2; D054834:Lipocalins / Q000652:urine*; D008875:Middle Aged; D011518:Proto-Oncogene Proteins / Q000652:urine*; D011933:Reagent Kits, Diagnostic; D015203:Reproducibility of Results
chemical_list: D000209:Acute-Phase Proteins; C489506:LCN2 protein, human; D000071068:Lipocalin-2; D054834:Lipocalins; D011518:Proto-Oncogene Proteins; D011933:Reagent Kits, Diagnostic